AbbVie Inc Asset Resilience Ratio

Latest as of December 2025: 0.02%

AbbVie Inc asset resilience ratio. AbbVie Inc (ABBV) has an Asset Resilience Ratio of 0.02% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of AbbVie Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$28.00 Million

Cash + Short-term Investments

Total Assets

$133.96 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of AbbVie Inc (2010–2025)

Asset resilience ratio of AbbVie Inc from 2010 to 2025. This chart shows how AbbVie Inc's Asset Resilience Ratio has changed over time. Read AbbVie Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down AbbVie Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ABBV current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$28.00 Million	0.02%
Total Liquid Assets	$28.00 Million	0.02%

Asset Resilience Insights

Limited Liquidity: AbbVie Inc maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

AbbVie Inc Industry Peers by Asset Resilience Ratio

Compare AbbVie Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. SHE:301096	Drug Manufacturers - General	1.58%
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	Drug Manufacturers - General	1.97%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Sanofi F:SNW2	Drug Manufacturers - General	0.37%
Sichuan Kelun Pharmaceutical Co Ltd SHE:002422	Drug Manufacturers - General	8.05%
Grifols S.A F:G0FB	Drug Manufacturers - General	0.12%
TTK Healthcare Limited NSE:TTKHLTCARE	Drug Manufacturers - General	68.81%
Eli Lilly and Company NYSE:LLY	Drug Manufacturers - General	0.13%

AbbVie Inc Asset Resilience Ratio by Year (2010–2025)

AbbVie Inc asset resilience ratio by year from 2010 to 2025. The table below shows the annual Asset Resilience Ratio data for AbbVie Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	$28.00 Million	$133.96 Billion	0.00pp
2024-12-31	0.02%	$31.00 Million	$135.16 Billion	+0.02pp
2023-12-31	0.00%	$2.00 Million	$134.71 Billion	-0.02pp
2022-12-31	0.02%	$28.00 Million	$138.81 Billion	-0.04pp
2021-12-31	0.06%	$84.00 Million	$146.53 Billion	+0.04pp
2020-12-31	0.02%	$30.00 Million	$150.56 Billion	--
2019-12-31	0.00%	$0.00	$89.11 Billion	--
2018-12-31	1.30%	$772.00 Million	$59.35 Billion	+0.61pp
2017-12-31	0.69%	$486.00 Million	$70.79 Billion	-1.31pp
2016-12-31	2.00%	$1.32 Billion	$66.10 Billion	+1.99pp
2015-12-31	0.02%	$8.00 Million	$53.05 Billion	-0.08pp
2014-12-31	0.09%	$26.00 Million	$27.51 Billion	-0.93pp
2013-12-31	1.03%	$300.00 Million	$29.20 Billion	-6.66pp
2012-12-31	7.68%	$2.08 Billion	$27.01 Billion	+4.48pp
2011-12-31	3.21%	$626.00 Million	$19.52 Billion	+3.20pp
2010-12-31	0.01%	$1.13 Million	$21.13 Billion	--

pp = percentage points

About AbbVie Inc

NYSE:ABBV USA Drug Manufacturers - General

Market Cap

$505.87 Billion

Market Cap Rank

#43 Global

#32 in USA

Share Price

$286.00

Change (1 day)

-0.98%

52-Week Range

$197.38 - $294.89

All Time High

$294.89